MARKET

VCEL

VCEL

Vericel
NASDAQ

Real-time Quotes | Nasdaq Last Sale

32.81
-0.21
-0.64%
After Hours: 33.35 +0.54 +1.65% 16:03 01/20 EST
OPEN
33.37
PREV CLOSE
33.02
HIGH
34.21
LOW
32.72
VOLUME
675.04K
TURNOVER
--
52 WEEK HIGH
68.94
52 WEEK LOW
32.73
MARKET CAP
1.54B
P/E (TTM)
-1038.2911
1D
5D
1M
3M
1Y
5Y
Vericel trims 2021 guidance below expectations
Vericel Corporation (VCEL -5.3%) is trading lower in morning hours after the company slashed its guidance for 2021 revenue growth to a range below the consensus. Ahead of its presentation
Seekingalpha · 01/12 15:04
BRIEF-Vericel Corp - Estimates Its Full-Year Revenue Growth For Fiscal Year 2021 To Be In The Range Of 25%-26%
reuters.com · 01/12 12:36
Vericel Sees FY21 Revenue Growth 25%-26%
In connection with its participation in the 40th Annual J.P. Morgan Healthcare conference on January 12, 2022, Vericel Corporation (the “Company”) updated its corporate presentation to include disclosure
Benzinga · 01/12 12:29
Jim Cramer Believes Penn National Is A Winner, Likes Vericel
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he likes Penn National Gaming, Inc. (NASDAQ: PENN), calling the stock as a winner.
Benzinga · 12/27/2021 12:24
Truist Securities Maintains Buy on Vericel, Lowers Price Target to $52
Truist Securities maintains Vericel (NASDAQ:VCEL) with a Buy and lowers the price target from $55 to $52.
Benzinga · 12/21/2021 12:33
Federated Hermes Adviser Series Buys Service Corp International, PerkinElmer Inc, Vericel Corp, ...
Investment company Federated Hermes Adviser Series (Current Portfolio) buys Service Corp International, PerkinElmer Inc, Vericel Corp, sells Ingredion Inc, PTC Inc during the 3-months ended 2021Q3, according to the most recent filings of the investment com...
GuruFocus.com · 12/17/2021 16:38
Brown Capital Management Small Company Fund Buys Ncino Inc, Duck Creek Technologies Inc, ...
Investment company Brown Capital Management Small Company Fund (Current Portfolio) buys Ncino Inc, Duck Creek Technologies Inc, Vericel Corp, CryoPort Inc, sells Glaukos Corp, Proto Labs Inc, Alteryx Inc, Blackbaud Inc, NetScout Systems Inc during the 3-mo...
GuruFocus.com · 12/13/2021 21:38
First Washington CORP Buys Air Products & Chemicals Inc, Lockheed Martin Corp, NorthWestern ...
GuruFocus News · 11/12/2021 18:23
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of VCEL. Analyze the recent business situations of Vericel through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 6 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

66.67%Strong Buy
33.33%Buy
0.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average VCEL stock price target is 58.46 with a high estimate of 68.00 and a low estimate of 50.00.
High68.00
Average58.46
Low50.00
Current 32.81
EPS
Actual
Estimate
-0.030.060.140.23
Q4 2020
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Institutional Holdings
Institutions: 285
Institutional Holdings: 64.42M
% Owned: 137.59%
Shares Outstanding: 46.82M
TypeInstitutionsShares
Increased
81
3.79M
New
20
335.61K
Decreased
71
1.53M
Sold Out
23
763.90K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
-0.61%
Pharmaceuticals & Medical Research
-0.75%
Key Executives
Non-Executive Chairman/Independent Director
Robert Zerbe
President/Chief Executive Officer/Director
Dominick Colangelo
Chief Financial Officer/Chief Accounting Officer
Joseph Mara
Chief Operating Officer
Michael Halpin
Vice President/General Counsel/Secretary
Sean Flynn
Other
Jonathan Hopper
Independent Director
Steven Gilman
Independent Director
Heidi Hagen
Independent Director
Kevin Mclaughlin
Independent Director
Alan Rubino
Independent Director
Paul Wotton
Independent Director
Lisa Wright
No Data
About VCEL
Vericel Corporation is a commercial-stage biopharmaceutical company. The Company specializes in cell therapies and specialty biologics for the sports medicine and severe burn care. It operates in one reportable segment, the research, product development, manufacture, and distribution of cellular therapies for use in the treatment of specific diseases. It markets two autologous cell therapy products in the United States, which includes MACI (autologous cultured chondrocytes on porcine collagen membrane) and Epicel (cultured epidermal autografts). The MACI is an autologous cellularized scaffold product indicated for the repair of symptomatic, single, or multiple full-thickness cartilage defects of the knee with or without bone involvement in adults. The Epicel is a permanent skin replacement humanitarian use device (HUD) for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns comprising greater than or equal to 30% of total body surface area (TBSA).

Webull offers kinds of Vericel Corp stock information, including NASDAQ:VCEL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VCEL stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading VCEL stock methods without spending real money on the virtual paper trading platform.